Literature DB >> 2144330

Peripheral nerve allograft: cellular and humoral immune responses of mice.

O Ishida1, M Ochi, Y Ikuta, M Akiyama.   

Abstract

Despite numerous experimental and clinical studies, no method has been established for achieving successful peripheral nerve allografts. One reason is that few studies concerning the immune response of the host have been conducted with nerve allografts. We therefore investigated the immune response of fresh nerve allografts with respect to both cellular and humoral immunological reactions. Using immunologically established strains of inbred mice, we performed the mixed lymphocyte culture (MLC) reaction and the cell-mediated lymphocytolysis reaction to test the cellular immune reaction and the complement-dependent cytotoxicity test to the humoral immune reaction. We observed that peripheral nerve tissues were strongly immunogenic; there was increased MLC reactivity to the allo-MHC antigen of the donor, specific cytotoxic T-cell activity, and production of specific antibody in the serum. For satisfactory nerve regeneration and transplantation, it is essential to suppress this immune response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144330     DOI: 10.1016/0022-4804(90)90125-l

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  3 in total

1.  Experience with nerve allograft transplantation.

Authors:  Ida K Fox; Susan E Mackinnon
Journal:  Semin Plast Surg       Date:  2007-11       Impact factor: 2.314

2.  Nerve allotransplantation as it pertains to composite tissue transplantation.

Authors:  Amy M Moore; Wilson Z Ray; Kristofer E Chenard; Thomas Tung; Susan E Mackinnon
Journal:  Hand (N Y)       Date:  2009-03-21

Review 3.  Reconstruction of Critical Nerve Defects Using Allogenic Nerve Tissue: A Review of Current Approaches.

Authors:  Tim Kornfeld; Anton Borger; Christine Radtke
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.